HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yasuhiro Miki Selected Research

estrogen sulfatase

4/2010Increased estrogen sulfatase (STS) and 17beta-hydroxysteroid dehydrogenase type 1(17beta-HSD1) following neoadjuvant aromatase inhibitor therapy in breast cancer patients.
2/2009New developments in intracrinology of human breast cancer: estrogen sulfatase and sulfotransferase.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yasuhiro Miki Research Topics

Disease

93Breast Neoplasms (Breast Cancer)
06/2022 - 06/2003
75Neoplasms (Cancer)
03/2022 - 12/2002
48Carcinoma (Carcinomatosis)
01/2022 - 06/2003
13Neoplasm Metastasis (Metastasis)
06/2022 - 07/2005
13Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 07/2005
11Lung Neoplasms (Lung Cancer)
02/2022 - 07/2011
11Noninfiltrating Intraductal Carcinoma (DCIS)
07/2017 - 03/2008
11Ductal Carcinoma
01/2017 - 03/2008
10Endometrial Neoplasms (Endometrial Cancer)
03/2022 - 10/2009
10Adenocarcinoma of Lung
05/2021 - 08/2010
9Lymphatic Metastasis
01/2022 - 05/2007
4Triple Negative Breast Neoplasms
02/2020 - 05/2013
3Lymphangioleiomyomatosis (Lymphangiomyomatosis)
02/2022 - 11/2015
3Hepatocellular Carcinoma (Hepatoma)
02/2018 - 08/2009
3Adenocarcinoma
02/2015 - 07/2005
3Disease Progression
05/2013 - 05/2007
3Neuroendocrine Tumors (Neuroendocrine Tumor)
03/2012 - 07/2007
2Alzheimer Disease (Alzheimer's Disease)
01/2022 - 08/2019
2Carcinogenesis
07/2021 - 09/2012
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2020 - 08/2013
2Adrenocortical Adenoma (Disease, Conn's)
01/2018 - 01/2009
2Osteosarcoma (Osteogenic Sarcoma)
10/2017 - 03/2008
2Lobular Carcinoma
02/2016 - 11/2014
2Inflammation (Inflammations)
09/2015 - 03/2004
2Ameloblastoma
09/2014 - 05/2013
2Lung Diseases (Lung Disease)
07/2014 - 11/2011
2Esophageal Squamous Cell Carcinoma
07/2012 - 02/2010

Drug/Important Bio-Agent (IBA)

68Estrogens (Estrogen)FDA Link
03/2022 - 12/2002
46Estrogen ReceptorsIBA
06/2022 - 11/2006
42Aromatase (CYP19)IBA
02/2018 - 01/2005
36EnzymesIBA
09/2021 - 12/2002
31AndrogensIBA
03/2022 - 12/2005
29Biological ProductsIBA
01/2022 - 06/2003
27Messenger RNA (mRNA)IBA
08/2019 - 06/2003
25Proteins (Proteins, Gene)FDA Link
02/2022 - 01/2006
23SteroidsIBA
10/2019 - 12/2002
21Aromatase InhibitorsIBA
10/2015 - 04/2007
16Hormones (Hormone)IBA
10/2018 - 11/2006
15Progesterone Receptors (Progesterone Receptor)IBA
12/2021 - 03/2004
15Androgen Receptors (Androgen Receptor)IBA
03/2018 - 03/2004
12Oxidoreductases (Dehydrogenase)IBA
10/2021 - 12/2005
11Biomarkers (Surrogate Marker)IBA
06/2022 - 01/2009
11ErbB Receptors (EGF Receptor)IBA
08/2021 - 09/2012
11Estradiol (Delestrogen)FDA LinkGeneric
03/2021 - 02/2008
8Tyrosine Kinase InhibitorsIBA
08/2021 - 10/2014
8MicroRNAs (MicroRNA)IBA
01/2021 - 07/2012
8Steryl-Sulfatase (Steroid Sulfatase)IBA
07/2011 - 06/2003
7CytokinesIBA
01/2021 - 01/2008
73 (or 17)-beta-hydroxysteroid dehydrogenaseIBA
06/2010 - 04/2007
7Estrogen Receptor alphaIBA
04/2009 - 03/2004
6TamoxifenFDA LinkGeneric
06/2022 - 07/2004
6Estrogen Receptor betaIBA
10/2012 - 03/2004
6estrone sulfotransferaseIBA
07/2011 - 06/2003
5Formaldehyde (Formol)FDA Link
12/2021 - 12/2010
5ParaffinIBA
12/2021 - 12/2010
5TOR Serine-Threonine KinasesIBA
02/2018 - 03/2012
5Steroid Receptors (Steroid Receptor)IBA
11/2011 - 03/2004
4human ERBB2 proteinIBA
12/2021 - 05/2013
4Dihydrotestosterone (Androstanolone)IBA
04/2018 - 02/2008
4Small Interfering RNA (siRNA)IBA
01/2016 - 02/2009
4RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
09/2012 - 03/2004
3lipoarabinomannan (LAM)IBA
02/2022 - 11/2015
3LigandsIBA
01/2022 - 09/2015
3Amyloid (Amyloid Fibrils)IBA
01/2022 - 11/2013
3Hydroxysteroid DehydrogenasesIBA
01/2020 - 12/2005
3ProstaglandinsIBA
09/2015 - 01/2005
3AntibodiesIBA
09/2014 - 11/2009
3Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
11/2013 - 01/2008
3Pregnane X ReceptorIBA
05/2010 - 01/2006
3EstroneFDA Link
02/2010 - 05/2007
3ERRalpha Estrogen-Related ReceptorIBA
11/2009 - 07/2004
3Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
11/2009 - 01/2005
3ProgesteroneFDA LinkGeneric
03/2008 - 07/2005
2Immune Checkpoint InhibitorsIBA
02/2022 - 01/2020
2Trastuzumab (Herceptin)FDA Link
12/2021 - 11/2018
2B7-H1 AntigenIBA
01/2021 - 08/2019
2Hydrocortisone (Cortisol)FDA LinkGeneric
01/2020 - 01/2018
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2020 - 11/2009
2Cytochromes c1 (Cytochrome c1)IBA
12/2019 - 07/2017
2Cell Adhesion MoleculesIBA
10/2019 - 11/2018
2Carcinoembryonic AntigenIBA
10/2019 - 11/2018
2Conditioned Culture MediaIBA
08/2019 - 01/2017
2LipidsIBA
08/2019 - 09/2015
2Gonadal Steroid Hormones (Sex Hormones)IBA
02/2018 - 11/2006
2Matrix Metalloproteinases (MMPs)IBA
02/2018 - 02/2014
2AldosteroneIBA
01/2018 - 06/2003
2Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA
01/2017 - 02/2014
2DNA (Deoxyribonucleic Acid)IBA
01/2017 - 05/2013
2Phenobarbital (Luminal)FDA Link
02/2016 - 05/2015
2NucleobindinsIBA
01/2016 - 01/2012
2Testosterone (Sustanon)FDA Link
09/2014 - 02/2008
2Monoclonal AntibodiesIBA
04/2014 - 11/2009
2Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
04/2014 - 01/2009
2Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
10/2010 - 07/2007

Therapy/Procedure

40Therapeutics
06/2022 - 07/2004
11Lasers (Laser)
11/2013 - 06/2003
5Drug Therapy (Chemotherapy)
02/2020 - 03/2010
3Ligation
12/2021 - 01/2017
2Neoadjuvant Therapy
05/2015 - 04/2010
2Aftercare (After-Treatment)
07/2012 - 04/2010